Integrin-mediated vectors for gene transfer and therapy

Current Opinion in Molecular Therapeutics

Volumn 1, Issue 2, 1999, Pages 197-203

  Hart, Stephen L ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INTEGRIN; INTEGRIN RECEPTOR; LIGAND; PEPTIDE; VIRUS VECTOR;

ARTICLE; CLONING VECTOR; EXPRESSION VECTOR; GENE TARGETING; GENE THERAPY; GENE TRANSFER; INTERNALIZATION; NONHUMAN; PHAGE DISPLAY; SIGNAL TRANSDUCTION;

GENE THERAPY; GENETIC VECTORS; INTEGRINS; LIGANDS; PEPTIDES; SIGNAL TRANSDUCTION; TRANSDUCTION, GENETIC; TRANSFECTION;

BACTERIA (MICROORGANISMS);

EID: 0033042566     PISSN: 14648431     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Felgner PL, Barenholz Y, Behr JP, Cheng SH, Cullis P, Huang L, Jessee JA, Seymour L, Szoka F, Thierry AR, Wagner E, Wu G: Nomenclature for synthetic gene delivery systems. Hum Gene Ther (1997) 8:511-512.
2. Hynes RO: Integrins: versatility, modulation, and signalling in cell adhesion. Cell (1992) 69:11-25.
3. Isberg RR, Tran Van Nhieu G: Binding and internalization of microorganisms by integrin receptors. Trends Microbiol (1994) 2:10-14.
4. Schlaepfer DD, Hunter T: Integrin signalling and tyrosine phosphorylation: just the FAKs? Trends Cell Biol (1998) 8:151-157. A review of inetgrin-mediated signaling pathways.
5. Li E, Stupack D, Klemke R, Cheresh DA, Nemerow GR: Adenovirus endocytosis via alpha(v) integrins requires phosphoinositide-3-OH kinase. J Virol (1998) 72:2055-2061. Integrin signaling pathway induced by adenovirus.
6. Wickham TJ, Tzeng E, Shears LL 2nd, Roelvink PW, Li Y, Lee GM, Brough DE, Lizonova A, Kovesdi I: Increased in vitro and in vivo gene transfer by adenovirus vectors containing chimeric fiber proteins. J Virol (1997) 71:8221-8229. Genetically engineered adenovirus displaying RGD peptide in fiber.
7. Basora N, Desloges N, Chang Q, Bouatrouss Y, Gosselin J, Poisson J, Sheppard D, Beaulieu JF: Expression of the α9β1 integrin in human colonic epithelial cells: resurgence of the fetal phenotype in a subset of colon cancers and adenocarcinoma cell lines. Int J Cancer (1998) 75:738-743.
8. Erbacher P, Remy J-S, Behr J-P: Gene transfer with synthetic virus-like particles via the integrin-mediated endocytosis pathway. Gene Therapy (1999) 6:138-145. Integrin-specific transfection by PEI-peptide molecular conjugates compexed with plasmid DNA displaying greatly enhanced efficiency over naked PEI.
9. Harbottle RP, Cooper RG, Hart SL, Ladhoff A, McKay T, Knight AM, Wagner E, Miller AD, Coutelle C: An RGD-oligolysine peptide: a prototype construct for integrin-mediated gene delivery. Hum Gene Ther (1998) 9:1037-1047. An integrin-mediated synthetic vector based on peptides, methods of enhancement.
10. Hart SL, Collins L, Gustafsson K, Fabre JW: Integrin-mediated transaction with peptides containing arginine-glycine-aspartic acid domains. Gene Ther (1997) 4:1225-1230. An integrin-mediated synthetic vector based on an integrin-binding peptide with a 16-lysine tail: optimization of transfection.
11. Hart SL, Arancibia-Carcamo CV, Wolfert MA, Mailhos C, O'Reilly NJ, Ali RR, Coutelle C, George AJ, Harbottle RP, Knight AM, Larkin DF, Levinsky RJ, Seymour LW, Thrasher AJ, Kinnon C: Lipid-mediated enhancement of transfection by a nonviral integrin-targeting vector. Hum Gene Ther (1998) 9:575-585. Integrin-specific gene transfer by a peptide/DNA complex enhanced by a cationic lipid.
12. Shewring L, Collins L, Ughtman SL, Hart S, Gustafsson K, Fabre JW: A nonviral vector system for efficient gene transfer to corneal endothelial cells via membrane integrlns. Transplantation (1997) 64:763-769. Application of integrin-targeting peptide/DNA complexes to the corneal endothelium.
13. McIntyre BW, Woodside DG, Caruso DA, Wooten DK, Simon SI, Neelamegham S, Revelle JK, Vanderslice P: Regulation of human T lymphocyte coactivation with an alpha4 integrin antagonist peptide. J Immunol (1997) 158:4180-4186.
14. Koivunen E, Wang B, Ruoslahti E: Isolation of a highly specific ligand for the α5β1 integrin from a phage display library. J Cell Biol (1994) 124:373-380.
15. 1-integrin-specific peptide.
16. Bergelson JM, Cunningham JA, Droguett G, Kurt-Jones EA, Krithivas A, Hong JS, Horwitz MS, Crowell RL, Finberg RW: Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science (1997) 275:1320-1323.
17. Pickles RJ, McCarty D, Matsui H, Hart PJ, Randell SH, Boucher RC: Limited entry of adenovirus vectors into well-differentiated airway epithelium is responsible for inefficient gene transfer. J Virol (1998) 72:6014-6023.
18. Goldman M, Su Q, Wilson JM: Gradient of RGD-dependent entry of adenoviral vector in nasal and intrapulmonary epithelia: implications for gene therapy of cystic fibrosis. Gene Ther (1996) 3:811-818.
19. Takayama K, Ueno H, Pei XH, Nakanishi Y, Yatsunami J, Hara N: The levels of integrin αvβ5 may predict the susceptibility to adenovirus-mediated gene transfer in human lung cancer cells. Gene Ther (1998) 5:361-368.
20. Meunier-Durmort C, Picart R, Ragot T, Perricaudet M, Hainque B, Forest C: Mechanism of adenovirus improvement of cationic liposome-mediated gene transfer. Biochim Biophys Acta (1997) 1330:8-16.
21. Kaplan JM, Pennington SE, St George JA, Woodworth LA, Fasbender A, Marshall J, Cheng SH, Wadsworth SC, Gregory RJ, Smith AE: Potentiation of gene transfer to the mouse lung by complexes of adenovirus vector and polycations improves therapeutic potential. Hum Gene Ther (1998) 9:1469-1479. Overcoming inhibitions imposed on the applications of adenoviruses to tissues lacking integrin receptors.
22. Walter E, Croyle MA, Roessler BJ, Amidon GL: The absence of accessible vitronectin receptors in differentiated tissue hinders adenoviral-mediated gene transfer to the intestinal epithelium in vitro. Pharm Res (1997) 14:1216-1222.
23. Hamilton TE, McClane SJ, Baldwin S, Burke C, Patel H, Rombeau JL, Raper SE: Efficient adenoviral-mediated murine neonatal small intestinal gene transfer is dependent on alpha(v) integrin expression. J Pediatr Surg (1997) 32:1695-1703.
24. Croyle MA, Walter E, Janich S, Roessler BJ, Amidon GL: Role of integrin expression in adenovirus-mediated gene delivery to the intestinal epithelium. Hum Gene Ther (1998) 9:561-573.
25. Bachmann AS, Surovoy A, Jung G, Moelling K: Integrin receptor-targeted transfer peptides for efficient delivery of antisense oligodeoxynudeotides. J Mol Med (1998) 76:126-132. A novel peptide-based delivery system delivering oligodeoxynucleotides via integrin receptors.
26. Paul RW, Weisser KE, Loomis A, Sloane DL, LaFoe D, Atkinson EM, Overall RW: Gene transfer using a novel fusion protein, GAL4/invasin. Hum Gene Ther (1997) 8:1253-1262. Integrin-mediated gene transfer using the bacterial protein invasin as the ligand.
27. Pasqualini R, Koivunen E, Ruoslahti E: Alpha v integrins as receptors for tumor targeting by circulating ligands Nat Biotechnol (1997) 15:542-546. Illustrates the complementary use of phage display technology for assessment of potential integrin-binding peptide ligands.
28. 1 integrins using phage display technology.
29. Cass DL, Bullard KM, Sylvester KG, Yang EY, Sheppard D, Herlyn M, Adzick NS: Epidermal integrin expression is upregulated rapidly in human fetal wound repair. J Pediatr Surg (1998) 33:312-316. Illustrates a window of opportunity for targeting specific integrins in damaged tissues.
30. Jabbour AJ, Altman LC, Wight TN, Luchtel DL: Ozone alters the distribution of β1 integrins in cultured primate bronchial epithelial cells. Am J Respir Cell Mol Biol (1998) 19:357-365. Targeting damaged tissues in the lung via integrins.
31. Kuga T, Sakamaki S, Matsunaga T, Hirayama Y, Kuroda H, Takahashi Y, Kusakabe T, Kato I, Niitsu Y: Fibronectin fragment-facilitated retroviral transfer of the glutatnione-S-transferase pi gene into CD34+ cells to protect them against alkylating agents. Hum Gene Ther (1997) 8:1901-1910.
32. Takahira H, Gotoh A, Ritchie A, Broxmeyer HE: Steel factor enhances integrin-mediated tyrosine phosphorylation of focal adhesion kinase (pp125FAK) and paxillin. Blood (1997) 89:1574-1584. An integrin-activation strategy that may facilitate integrin-targeted gene transfer to hemalopoietic cells.
33. Gotoh A, Ritchie A, Takahira H, Broxmeyer HE: Thrombopoietin and erythropoietin activate inside-out signaling of integrin and enhance adhesion to immobilized fibronectin in human growth-factor-dependent hematopoietic cells. Ann Hematol (1997) 75:207-213. An integrin activation strategy for hematopoietic cells.
34. Fenczik CA, Sethi T, Ramos JW, Hughes PE, Ginsberg MH: Complementation of dominant suppression implicates CD98 in integrin activation. Nature (1997) 390:81-85. A potential integrin activation approach with potential for a range of cell types.
35. Davison E, Diaz RM, Hart IR, Santis G, Marshall JF: Integrin α5β1-mediated adenovirus infection is enhanced by the integrin-activatlng antibody TS2/16. J Virol (1997) 71:6204-6207.